Evidence map›Paper›PMID 34045202›Full record

ArticleBMJ case reports2021

Megumi Sato, Ruri Kato, Ryu Jokoji, Isao Tachibana

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 1 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Megumi SatoDepartment of Medicine, Nippon Life Hospital, Osaka, Osaka, Japan.
Ruri KatoDepartment of Medicine, Nippon Life Hospital, Osaka, Osaka, Japan.
Ryu JokojiDepartment of Pathology, Nippon Life Hospital, Osaka, Osaka, Japan.
Isao TachibanaDepartment of Medicine, Nippon Life Hospital, Osaka, Osaka, Japan tachibana.isao@k.nissay-hp.or.jp.
Nippon Medical School Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eosinophilia in asthma or rhinitis is usually considered to be reactive to the allergic diseases. We report a 33-year-old man with asthma and rhinitis, and progressive hypereosinophilia. Fluorescence in situ hybridization analysis detected interstitial chromosomal deletion at 4q12 in cells of the bone marrow. The patient was diagnosed as myeloproliferative neoplasm with a

Indexed as

AsthmaHypereosinophilic SyndromeRhinitisAdultBenzamidesHumansIn Situ Hybridization, FluorescenceMalemRNA Cleavage and Polyadenylation FactorsOncogene Proteins, FusionPiperazinesPyrimidinesReceptor, Platelet-Derived Growth Factor alphaBenzamidesFIP1L1-PDGFRA fusion protein, humanmRNA Cleavage and Polyadenylation FactorsOncogene Proteins, FusionPiperazinesPyrimidinesReceptor, Platelet-Derived Growth Factor alphaasthmaoncology

Identifiers

PMID34045202
PMCPMC8162092
OpenAlexW3163976533

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.